Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Heim

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Journal of Cancer Research and Clinical Oncology|January 1, 1984
Treatment of autochthonous rat colonic adenocarcinomas with a thioether-lysophospholipid derivative in mono- and combination chemotherapyM E Heim, M Swoboda, W Pahlke, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1981
Central nervous side effects following ifosfamide monotherapy of advanced renal carcinomaM E Heim, R Fiene, E Schick, et al.
Onkologie|August 1, 1989
Sequential high dose methotrexate, 5-fluorouracil and folinic acid does not improve response rates in advanced colorectal cancerM E Heim, D Schuster, H Flechtner, et al.
Onkologie|December 1, 1987
[Phase III study of chemotherapy in low-malignancy non-Hodgkin's lymphomas: comparison of vincristine-vindesine combination chemotherapy]M E Heim, D Fritze, A D Ho, et al.
Onkologie|October 1, 1989
Dose escalation and split course of 4-epidoxorubicin in combination chemotherapy (FEM II) of advanced gastric carcinoma. A phase-II trail of the 'Chemotherapiegruppe Gastrointestinaler Tumoren (CGT)'W Queisser, H Flechtner, M E Heim, et al.
Arzneimittel-Forschung|June 1, 1989
Assessment of the preclinical activity of budotitane in three different transplantable tumor systems, its lack of mutagenicity, and first results of clinical phase I studiesB K Keppler, M E Heim, H Flechtner, et al.
Onkologie|February 1, 1990
[Treatment of advanced pancreatic cancer with 5-fluorouracil, 4-epidoxorubicin and mitomycin C (FEM II). From the Chemotherapy of Gastrointestinal Tumors Group]S Verhees, H Flechtner, W Queisser, et al.
Onkologie|October 1, 1986
Phase-II studies of 1,2,4-triglycidylurazol (TGU) in solid tumors. Phase-II Study Group of the Association of Medical Oncology of the German Cancer SocietyW Queisser, H E Wander, K Possinger, et al.
Blut|June 1, 1988
Response-oriented therapy with CHOP and VIM-Bleo in high-grade malignant non-Hodgkin's lymphomasB Steinke, H U Krüger, H Kraft, et al.
Onkologie|December 1, 1990
Tumor necrosis factor in advanced colorectal cancer: a phase II study. A trial of the phase I/II study group of the Association for Medical Oncology of the German Cancer SocietyM E Heim, R Siegmund, H J Illiger, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Journal of Cancer Research and Clinical Oncology|January 1, 1984
Treatment of autochthonous rat colonic adenocarcinomas with a thioether-lysophospholipid derivative in mono- and combination chemotherapyM E Heim, M Swoboda, W Pahlke, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1981
Central nervous side effects following ifosfamide monotherapy of advanced renal carcinomaM E Heim, R Fiene, E Schick, et al.
Onkologie|August 1, 1989
Sequential high dose methotrexate, 5-fluorouracil and folinic acid does not improve response rates in advanced colorectal cancerM E Heim, D Schuster, H Flechtner, et al.
Onkologie|December 1, 1987
[Phase III study of chemotherapy in low-malignancy non-Hodgkin's lymphomas: comparison of vincristine-vindesine combination chemotherapy]M E Heim, D Fritze, A D Ho, et al.
Onkologie|October 1, 1989
Dose escalation and split course of 4-epidoxorubicin in combination chemotherapy (FEM II) of advanced gastric carcinoma. A phase-II trail of the 'Chemotherapiegruppe Gastrointestinaler Tumoren (CGT)'W Queisser, H Flechtner, M E Heim, et al.
Arzneimittel-Forschung|June 1, 1989
Assessment of the preclinical activity of budotitane in three different transplantable tumor systems, its lack of mutagenicity, and first results of clinical phase I studiesB K Keppler, M E Heim, H Flechtner, et al.
Onkologie|February 1, 1990
[Treatment of advanced pancreatic cancer with 5-fluorouracil, 4-epidoxorubicin and mitomycin C (FEM II). From the Chemotherapy of Gastrointestinal Tumors Group]S Verhees, H Flechtner, W Queisser, et al.
Onkologie|October 1, 1986
Phase-II studies of 1,2,4-triglycidylurazol (TGU) in solid tumors. Phase-II Study Group of the Association of Medical Oncology of the German Cancer SocietyW Queisser, H E Wander, K Possinger, et al.
Blut|June 1, 1988
Response-oriented therapy with CHOP and VIM-Bleo in high-grade malignant non-Hodgkin's lymphomasB Steinke, H U Krüger, H Kraft, et al.
Onkologie|December 1, 1990
Tumor necrosis factor in advanced colorectal cancer: a phase II study. A trial of the phase I/II study group of the Association for Medical Oncology of the German Cancer SocietyM E Heim, R Siegmund, H J Illiger, et al.
Pageof 5